A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Introduction: Bortezomib-induced peripheral neuropathy typically presents as a painful, length-dependent sensory predominant neuropathy. Methods: A case report, including nerve pathology, is presented of a man with multiple myeloma who developed a severe motor predominant polyradiculoneuropathy in the setting of bortezomib treatment. We also review the Mayo Clinic Hematology Dysproteinemia database for patients treated with bortezomib. Results: A 53-year-old man with Stage III multiple myeloma developed a severe motor predominant polyradiculoneuropathy following bortezomib treatment with electrophysiological features of multiple conduction blocks and pathological evidence of peripheral nerve microvasculitis. Our institutional experience is that 36.5% of dysproteinemia patients treated with bortezomib develop treatment-emergent peripheral neuropathy, and the most common pattern is a painful sensory predominant peripheral neuropathy. Conclusions: A motor predominant polyradiculoneuropathy is a rare presentation of bortezomib-associated peripheral neuropathy in multiple myeloma patients which may progress despite treatment withdrawal and may be due to microvasculitis.

Original languageEnglish (US)
Pages (from-to)964-970
Number of pages7
JournalMuscle and Nerve
Volume46
Issue number6
DOIs
StatePublished - Dec 2012

Keywords

  • Bortezomib
  • Conduction block
  • Microvasculitis
  • Multiple myeloma
  • Polyradiculoneuropathy

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Fingerprint Dive into the research topics of 'A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment'. Together they form a unique fingerprint.

  • Cite this